Barclays analyst Steve Valiquette reiterated an Overweight rating and $20.00 price target on Teladoc (NYSE: TDOC).The analyst commented, "TDOC announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE